Baisakhi Saha
Overview
Explore the profile of Baisakhi Saha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
291
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaur P, Ward B, Saha B, Young L, Groshen S, Techy G, et al.
J Histochem Cytochem
. 2011 Oct;
59(12):1087-100.
PMID: 22034518
Progress in our understanding of heterotypic cellular interaction in the tumor microenvironment, which is recognized to play major roles in cancer progression, has been hampered due to unavailability of an...
2.
Lahiry L, Saha B, Chakraborty J, Adhikary A, Mohanty S, Sakib Hossain D, et al.
Carcinogenesis
. 2009 Dec;
31(2):259-68.
PMID: 19969555
The most common alterations found in breast cancer are inactivation or mutation of tumor suppressor gene p53. The present study revealed that theaflavins induced p53-mutated human breast cancer cell apoptosis....
3.
Das T, Sa G, Saha B, Das K
Mol Cell Biochem
. 2009 Oct;
336(1-2):85-95.
PMID: 19826768
Although safe in most cases, ancient treatments are ignored because neither their active components nor their molecular targets are well defined. This is not the case, however, with curcumin, a...
4.
Chattopadhyay S, Bhattacharyya S, Saha B, Chakraborty J, Mohanty S, Sakib Hossain D, et al.
PLoS One
. 2009 Oct;
4(10):e7382.
PMID: 19812686
Background: Many tumors are associated with decreased cellular immunity and elevated levels of prostaglandin E2 (PGE2), a known inhibitor of CD4+ T cell activation and inducer of type-2 cytokine bias....
5.
Pillai M, Hariharan R, Babu J, Lakshmi S, Chiplunkar S, Patkar M, et al.
Int J Cancer
. 2009 Apr;
125(1):91-103.
PMID: 19358280
Human papilloma virus is a causative factor in the etiology of cervical cancer with HPV16 being the most prevalent genotype associated with it. Intratype variations in oncogenic E6/E7 and capsid...
6.
Shuangshoti S, Thorner P, Ruangvejvorachai P, Saha B, Groshen S, Taylor C, et al.
Neuropathology
. 2008 Nov;
29(5):521-7.
PMID: 19019178
J1-31 is one of the astrocytic proteins, the expression of which has not been evaluated in astrocytomas. In the present study, we studied the expression of J1-31 protein in astrocytes...
7.
Saha B, Kaur P, Tsao-Wei D, Naritoku W, Groshen S, Datar R, et al.
Prostate
. 2008 Aug;
68(15):1681-8.
PMID: 18712716
Background: The concurrent determination of methylation status of E-cadherin gene and E-cadherin protein expression remains scant in metastatic prostate cancer cells in bone, the most prevalent site for metastatic growth....
8.
Lahiry L, Saha B, Chakraborty J, Bhattacharyya S, Chattopadhyay S, Banerjee S, et al.
Apoptosis
. 2008 May;
13(6):771-81.
PMID: 18454316
Theaflavins, the bioactive flavonoids of black tea, have been demonstrated to inhibit proliferation and induce apoptosis in a variety of cancer cells. However, the contribution of p53 in mammary epithelial...
9.
Saha B, Chaiwun B, Imam S, Tsao-Wei D, Groshen S, Naritoku W, et al.
Anticancer Res
. 2008 Jan;
27(6B):3903-8.
PMID: 18225549
Aim: The aim of the present study was to evaluate E-cadherin, whose expression remains poorly understood in the intercellular adhesion of metastatic breast cancer cells in bone, the most prevalent...
10.
Saha B, Arase A, Imam S, Tsao-Wei D, Naritoku W, Groshen S, et al.
Prostate
. 2007 Nov;
68(1):78-84.
PMID: 18008331
Background: The expression of E-cadherin in the intercellular adhesion of metastatic prostate cancer cells in bone, which is the most prevalent site of metastatic growth, remains elusive. Methods: The aim...